References

Baker E, Brown E, Warnes C Managing Sound Sensitivities in Companion Animal Patients. Vet Times (Peterb). 2020;

Christensen T, White J, 2nd edn. (Eds). Wiley-Liss: Finger, Silver & Restrepo; 2000

Cozzi A, Lecuelle CL, Monneret P, Articlaux F, Bougrat L, Mengoli M, Pageat P Induction of scratching behaviour in cats: efficacy of synthetic feline interdigital semiochemical. J Feline Med Surg. 2013; 15:(10)872-878 https://doi.org/10.1177/1098612X13479114

An initial open-label study of a novel pheromone complex for use in cats. 2021. https://www.scirp.org/journal/ojvm

Denenberg S, Landsberg GM Effects of dog-appeasing pheromones on anxiety and fear in puppies during training and on long-term socialization. J Am Vet Med Assoc. 2008; 233:(12)1874-1882 https://doi.org/10.2460/javma.233.12.1874

DePorter TL, Bledsoe DL, Beck A, Ollivier E Evaluation of the efficacy of an appeasing pheromone diffuser product vs placebo for management of feline aggression in multi-cat households: a pilot study. J Feline Med Surg. 2019; 21:(4)293-305 https://doi.org/10.1177/1098612X18774437

Falewee C, Gaultier E, Lafont C, Bougrat L, Pageat P Effect of a synthetic equine maternal pheromone during a controlled fear-eliciting situation. Appl Anim Behav Sci. 2006; 101:(1-2)144-153 https://doi.org/10.1016/j.applanim.2006.01.008

Griffith CA, Steigerwald ES, Buffington CAT Effects of a synthetic facial pheromone on behavior of cats. J Am Vet Med Assoc. 2000; 217:(8)1154-1156 https://doi.org/10.2460/javma.2000.217.1154

Hargrave C Pheromonatherapy and animal behaviour: providing a place of greater safety. Companion Anim. 2014; 19:(2)60-64 https://doi.org/10.12968/coan.2014.19.2.60

Maslow AH A theory of human motivation. Psychol Rev. 1943; 50:(4)370-396 https://doi.org/10.1037/h0054346

Mills DS, Ramos D, Estelles MG, Hargrave C A triple blind placebo-controlled investigation into the assessment of the effect of Dog Appeasing Pheromone (DAP) on anxiety related behaviour of problem dogs in the veterinary clinic. Appl Anim Behav Sci. 2006; 98:(1-2)114-126 https://doi.org/10.1016/j.applanim.2005.08.012

Mills D, Braem Dube M, Zulch HChichester: John Wiley & Sons; 2013

Pageat P The science behind the new pheromone discovery. The Proceedings of the International Society of Feline Medicine International Feline Congress. 2020;

PDSA. PAW Report. 2020. https://www.pdsa.org.uk/media/10540/pdsapaw-report-2020.pdf (accessed 14 April, 2021)

Sparkes A Feliway Optimum: Clinical Evidence. The Proceedings of the International Society of Feline Medicine International Feline Congress. 2020b;

Wyatt TDCambridge: Cambridge University Press; 2003

Pheromones and 25 years of pheromonotherapy: what are they and how do they work?

02 April 2021
13 mins read
Volume 12 · Issue 3
Figure 1. Flehmen and the vomeronasal organ.

Abstract

The capacity of animals to communicate via pheromones is long established and, for generations, pheromones have been unwittingly used by man to manage the behaviour of animals in agriculture — using the chemicals produced by an individual member of a species to alter the behaviour of another member of that species. More recently, insect pheromones have been used in managing insect infestations of crops. However, approximately 25 years ago the French veterinary surgeon, Patrick Pageat, began to investigate the production of pheromones in both farm and companion animals and how synthetic analogues of pheromones could be used to improve animal welfare, creating a new field in veterinary medicine — pheromonotherapy. This article aims to summarise the main developments in pheromonotherapy over the last 25 years.

Behaviour problems remain a major underlying cause of abandonment and euthanasia of companion animals, particularly the dog and cat (PDSA, 2020). In addition, anxiety and fear-related behaviours of companion animals within the veterinary practice environment are a major basis for owners delaying the presentation of animals for essential veterinary treatment. For approximately 25 years there has been a growing wealth of evidence to support the use of synthetic analogues of canine and feline pheromones to assist in the treatment and prevention of the development of behaviour problems (Landsberg, 2015). Such products have, in combination with environmental management, behaviour modification and, where necessary, concurrent medication, supported the behavioural welfare of millions of companion animals, worldwide. Yet many veterinary staff remain unsure of the nature, mechanism of activity and advantages of the use of pheromonotherapy within patients' homes or within the practice environment.

Register now to continue reading

Thank you for visiting The Veterinary Nurse and reading some of our peer-reviewed content for veterinary professionals. To continue reading this article, please register today.